Key result
Chronic low-grade inflammation is linked to obesity and T2D progression, highlighting markers for risk assessment.
Why the study?
Overweight, obesity, and type 2 diabetes mellitus are rising global health problems, and understanding the role of inflammation may help alleviate these diseases.
Design
Review
Authors
Loading...
May aid risk stratification in obesity and T2D; leaves open need for prospective validation before clinical use.
Chronic low-grade inflammation is a key pathophysiological mechanism in obesity and type 2 diabetes, suggesting inflammatory markers could serve as risk assessment tools and therapeutic targets.
Lempesis et al. (2023) conducted a review in Obesity and type 2 diabetes mellitus. Chronic low-grade inflammation plays a significant role in the development and progression of obesity and type 2 diabetes, suggesting inflammatory markers may help assess disease risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: